Page last updated: 2024-08-21

isoxazoles and Anochlesia

isoxazoles has been researched along with Anochlesia in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (23.08)	18.7374
1990's	4 (30.77)	18.2507
2000's	4 (30.77)	29.6817
2010's	2 (15.38)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barton, HA; Danhof, M; de Greef, R; Grimwood, S; Groothuis, GM; Johnson, M; Kozielska, M; Pilla Reddy, V; Proost, JH; Vermeulen, A	1
Harada, Y; Koh, T; Nagino, K	1
Cho, H; Cho, YS; Choi, KI; Jeong, D; Jung, JY; Jung, SH; Kim, GD; Koh, HY; Kong, JY; Lee, S; Pae, AN; Park, WK; Yun, CW	1
Cha, MY; Cho, H; Choi, KI; Jeong, D; Koh, HY; Kong, JY; Lee, SJ; Pae, AN; Park, WK	1
Brea, J; Cabrero-Castel, A; Castro, M; Dezi, C; Fernández-Espejo, E; Galán-Rodríguez, B; Loza, MI; Maldonado, R; Masaguer, CF; Pastor, M; Raviña, E; Robledo, P; Sanz, F	1
Arnt, J; Christensen, AV	1
Conway, PC; Corbett, R; Dunn, RW; Hartman, H; Helsley, GC; Kerman, LL; Strupczewski, JT; Woods, AT	1
Hayakawa, H; Kawai, K; Kikumoto, O; Motohashi, N; Okamoto, Y; Yamawaki, S; Yokota, N	1
Agut, J; Anglada, L; Bolós, J; De la Fuente, N; Gubert, S; Ortiz, JA; Planas, JM; Príncep, M; Sacristán, A	1
Cadavid, MI; Carotti, A; Carrieri, A; Cid, J; Fontenla, JA; Loza, MI; Lozoya, E; Masaguer, CF; Negreira, J; Raviña, E; Rivas, ME; Rosa, E; Sanz, F; Tristán, H	1
Cadavid, MI; Casariego, I; Demontis, GC; Enguix, MJ; Fontenla, JA; Loza, MI; Masaguer, CF; Montenegro, GY; Raviña, E; Rivas, ME; Villazon, M	1
De Montis, GM; Mulas, G; Olianas, MC; Tagliamonte, A	1
Catt, JD; Eison, MS; Lobeck, WG; Minielli, JL; New, JS; Riblet, LA; Smith, DW; Taylor, DP; Temple, DL; Yevich, JP	1

Reviews

1 review(s) available for isoxazoles and Anochlesia

Article	Year
[Pharmacological properties of paliperidone ER (INVEGA(®)) and results of its clinical studies]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2011, Volume: 137, Issue:6 Topics: Animals; Behavior, Animal; Catalepsy; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Double-Blind Method; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Randomized Controlled Trials as Topic; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Schizophrenia; Secondary Prevention	2011

Article

Year

[Pharmacological properties of paliperidone ER (INVEGA(®)) and results of its clinical studies].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2011, Volume: 137, Issue:6

Topics: Animals; Behavior, Animal; Catalepsy; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Double-Blind Method; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Randomized Controlled Trials as Topic; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Schizophrenia; Secondary Prevention

2011

Other Studies

12 other study(ies) available for isoxazoles and Anochlesia

Article	Year
Dopamine D2 receptor occupancy as a predictor of catalepsy in rats: a pharmacokinetic-pharmacodynamic modeling approach. Pharmaceutical research, 2014, Volume: 31, Issue:10 Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Catalepsy; Computer Simulation; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Humans; Isoxazoles; Markov Chains; Models, Biological; Olanzapine; Paliperidone Palmitate; Pyrimidines; Rats; Receptors, Dopamine D2; Risperidone; Severity of Illness Index	2014
Pharmacological actions of a novel and selective dopamine D3 receptor antagonist, KCH-1110. Pharmacological research, 2003, Volume: 48, Issue:6 Topics: Animals; Antipsychotic Agents; Benzamides; Binding, Competitive; Body Temperature; Catalepsy; Cell Line; Clozapine; Cocaine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; Humans; Hypothermia; Isoxazoles; Male; Mice; Motor Activity; Prolactin; Psychomotor Performance; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrahydronaphthalenes; Thiophenes; Tritium	2003
KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia. Pharmacology, biochemistry, and behavior, 2005, Volume: 82, Issue:2 Topics: Animals; Antipsychotic Agents; Body Temperature; Catalepsy; Cell Line; Dopamine Uptake Inhibitors; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ion Channels; Isoxazoles; Male; Mice; Mice, Inbred ICR; Piperazines; Postural Balance; Prolactin; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D1; Receptors, Dopamine D3; Receptors, Dopamine D4; Reflex, Startle; Schizophrenia; Schizophrenic Psychology; Serotonin Receptor Agonists; Spiperone; Swimming	2005
QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine. Neuropharmacology, 2006, Volume: 51, Issue:2 Topics: Animals; Antipsychotic Agents; Butyrophenones; Carbazoles; Catalepsy; CHO Cells; Clozapine; Cricetinae; Cricetulus; Humans; In Vitro Techniques; Isoxazoles; Male; Mice; Models, Molecular; Motor Activity; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Histamine H1; Receptors, Muscarinic; Receptors, Serotonin; Reflex, Startle; Stereotyped Behavior	2006
Differential reversal by scopolamine and THIP of the antistereotypic and cataleptic effects of neuroleptics. European journal of pharmacology, 1981, Jan-05, Volume: 69, Issue:1 Topics: Amphetamine; Animals; Antipsychotic Agents; Catalepsy; Humans; Isoxazoles; Male; Oxazoles; Rats; Scopolamine; Stereotyped Behavior	1981
Effects of atypical antipsychotic agents on social behavior in rodents. Pharmacology, biochemistry, and behavior, 1993, Volume: 45, Issue:1 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Apomorphine; Benzazepines; Catalepsy; Chlorpromazine; Clozapine; Diazepam; Haloperidol; Isoxazoles; Male; Mice; Mice, Inbred Strains; Piperidines; Raclopride; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Salicylamides; Social Behavior	1993
[Effects of risperidone on catalepsy and cerebral dopamine, serotonin and GABA metabolism in the rat: comparison with haloperidol]. Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology, 1993, Volume: 13, Issue:1 Topics: Animals; Antipsychotic Agents; Brain; Catalepsy; Dopamine; gamma-Aminobutyric Acid; Haloperidol; Isoxazoles; Male; Piperidines; Rats; Rats, Wistar; Risperidone; Serotonin	1993
7-[3-(1-piperidinyl)propoxy]chromenones as potential atypical antipsychotics. 2. Pharmacological profile of 7-[3-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)-piperidin-1-yl]propoxy]-3-(hydroxymeth yl)chromen -4-one (abaperidone, FI-8602). Journal of medicinal chemistry, 1998, Dec-31, Volume: 41, Issue:27 Topics: Administration, Oral; Animals; Antipsychotic Agents; Brain; Catalepsy; Cell Line; Chromones; Drug Evaluation, Preclinical; Guinea Pigs; Humans; Isoxazoles; Male; Mice; Motor Activity; Prolactin; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Neurotransmitter; Stereotyped Behavior; Structure-Activity Relationship	1998
Conformationally constrained butyrophenones with mixed dopaminergic (D(2)) and serotoninergic (5-HT(2A), 5-HT(2C)) affinities: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and -thienocycloalkanones as putative atypical an Journal of medicinal chemistry, 1999, Jul-29, Volume: 42, Issue:15 Topics: Animals; Antipsychotic Agents; Aorta, Thoracic; Brain; Catalepsy; Cattle; Dopamine Agents; In Vitro Techniques; Isoxazoles; Male; Mice; Models, Molecular; Motor Activity; Muscle Contraction; Muscle, Smooth, Vascular; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin Agents; Structure-Activity Relationship; Thiophenes	1999
Conformationally constrained butyrophenones with affinity for dopamine (D(1), D(2), D(4)) and serotonin (5-HT(2A), 5-HT(2B), 5-HT(2C)) receptors: synthesis of aminomethylbenzo[b]furanones and their evaluation as antipsychotics. Journal of medicinal chemistry, 2000, Nov-30, Volume: 43, Issue:24 Topics: Animals; Antipsychotic Agents; Behavior, Animal; Binding, Competitive; Butyrophenones; Catalepsy; Cattle; Corpus Striatum; Frontal Lobe; Humans; In Vitro Techniques; Isoxazoles; Male; Mice; Piperidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, Serotonin; Retina	2000
The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral GABAergic pathway. European journal of pharmacology, 1978, Jun-01, Volume: 49, Issue:3 Topics: Aminobutyrates; Animals; Catalepsy; Corpus Striatum; Dopamine; Functional Laterality; GABA Antagonists; gamma-Aminobutyric Acid; Humans; Isoxazoles; Male; Neural Inhibition; Neural Pathways; Picrotoxin; Rats; Stereotyped Behavior; Substantia Nigra	1978
Synthesis and biological evaluation of 1-(1,2-benzisothiazol-3-yl)- and (1,2-benzisoxazol-3-yl)piperazine derivatives as potential antipsychotic agents. Journal of medicinal chemistry, 1986, Volume: 29, Issue:3 Topics: Animals; Antipsychotic Agents; Avoidance Learning; Binding, Competitive; Catalepsy; Cerebral Cortex; Corpus Striatum; Isoxazoles; Male; Models, Molecular; Norepinephrine; Oxazoles; Physostigmine; Piperazines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Serotonin; Sleep; Spiro Compounds; Stereotyped Behavior; Structure-Activity Relationship; Thiazoles	1986